Stem Cell Agency Awards $39 Million [California]
By Los Angeles Times,
Los Angeles Times
| 09. 10. 2005
California's stem cell research agency awarded the first of a planned $3 billion in grants Friday, announcing that a little less than $39 million would go to UCLA, UC Irvine, Stanford and several other campuses to help set up programs to train scientists.
Although the amount was relatively small, competition among 26 universities and nonprofit institutions was stiff because those selected hope to be at the front of the line for more lucrative public financing to come.
The agency's Independent Citizens' Oversight Committee chose 16 winners.
The agency, the California Institute for Regenerative Medicine, was set up by Proposition 71, which voters passed last year to fund a program of research using embryonic stem cells to develop potential treatments for disease.
For now, the institute doesn't have any of its own money to give out. Lawsuits filed by anti-tax and antiabortion groups have blocked the state from issuing the bonds that Proposition 71 authorized.
As a result, the agency's chairman, Robert Klein, has been asking private philanthropic groups to fill the void with the expectation that they will be repaid...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
